• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ INFUSION SET C50

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ INFUSION SET C50 Back to Search Results
Catalog Number 515300
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Information (3190)
Event Date 12/27/2018
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation and/or device history review, a supplemental report will be filed.
 
Event Description
It was reported that before use of the bd phaseal¿ infusion set c50 the package was open in two places on one side.
 
Manufacturer Narrative
Investigation summary: a device history review was performed and found no non-conformances associated with this issue during the production of this batch.One sample was received for investigation at sendai facilities.Issue is confirmed as the tubing appear cutting in the sealing area of the unit packaging.Visual inspection of the sample confirmed the issue.One unit appear to be opened by one side due a bad disposition of the set into the blister.Both drip chamber cap and male luer lock cap have been placed too close to the sealing area of the film+paper, resulting in the issue detected by the customer.The set is manually assembled and then is inserted into the blister machine, which seals the film and paper to form the unit package.Finally, one packaging operator inserts the sets into a carton box.Manpower could be considered as part of the root cause of the problem as the operator did not correctly place the set into the blister machine, placing the tubing in the sealing area of the blister packaging.Furthermore, take into account the result of the visual inspection, it could be that a defective unit was not detected during packaging or during quality controk, as this is done according to a sampling plan.Inspections and test: inspections an test are performed by sendal according to sb1739.Take into account the complaints trend history (no related complaints) and the result of the visual inspection of the sample the most probably root cause could be a punctual bad disposition of the set into the blister produced by one operator.
 
Event Description
It was reported that before use of the bd phaseal¿ infusion set c50 the package was open in two places on one side.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ INFUSION SET C50
Type of Device
INFUSION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key8261265
MDR Text Key133851268
Report Number3003152976-2019-00003
Device Sequence Number1
Product Code LHI
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 02/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/09/2021
Device Catalogue Number515300
Device Lot NumberTA10662
Date Manufacturer Received01/02/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-